NasdaqGS: TSEM · Tower Semiconductor Ltd.Enhanced Equity Research · Aug 18, 2026
PriceThesisFundamentalsCatalystsEarningsPeersValuationTechnicalsConvictionRisksSummary
Equity Research Report
Analysis by Joseph Lefcoe
Enhanced Equity Research — Tower Semiconductor Ltd. (TSEM)
Specialty Foundry · AI PhotonicsNasdaqGS: TSEM · $29.7B capQualitative Research · Aug 2026

TSEM

Tower Semiconductor Ltd. — Enhanced Equity Research
Current Price
$263.73
Market Cap
$29.7B
52-Week High
$319.94
52-Week Low
$47.97
HOLD
PT $278
+5% upside · Medium conviction

1-Year Price & Key Levels

Price 50-DMA 200-DMA Price target
Chart data: Yahoo Finance, as of Aug 17, 2026
$30.48$107$183$259$336SepDecMarJun PT $278Bear $165 $265
RSI(14) 57.750-DMA $244200-DMA $176vs 52w high -17.6%52w range position 79%

The AI Bottleneck Foundry — Priced for the 2028 Model

Tower Semiconductor has transformed from a sleepy specialty-analog foundry into the pure-play fab for AI optical interconnects. Its silicon photonics annual run rate exploded from $180M a year ago to $680M in Q2 2026, on track to cross $1B by Q4, with $1.3B of contracted 2027 SiPho revenue backed by $290M in customer prepayments and a raised, customer-backed 2028 model of $3.6B revenue / $1.2B net profit. Q2 revenue hit a record $460M (+24% YoY); Q3 is guided to a record $520M (+31%). A $3B METI-supported Japan expansion (net of ~$1B in grants) multiplies SiPho/SiGe capacity, while Nvidia and Marvell collaborations validate the 1.6T optics roadmap. But the ~5x move off the $47.97 low already prices in much of this: ~68x FY2026 and ~40x FY2027 consensus EPS versus GlobalFoundries at 23.5x forward. The thesis now reduces to one variable — flawless execution of the capacity ramp; a delay compresses the multiple hard, delivery makes the 2028 numbers reachable. We initiate at HOLD: buy the pullbacks, not the chase.

A five-bagger priced for flawless execution — The ~450% move off the October low tracks the SiPho revenue inflection — record quarters, $1.3B of prepaid 2027 contracts, and a METI-backed capacity plan — leaving valuation, not demand, as the open question.

Price (2026-08-17)
$263.73
RSI(14) 57.7 · 50-DMA $244.44 · 200-DMA $176.45
Market Cap
$29.7B
112,534,404 shares outstanding (2025-12-31)
52-Week Range
$47.97–$319.94
Up ~450% off the low · −17.6% from the high
Q2 2026 Revenue
$460M
Record · +24% YoY · gross profit $138M (+72%) · diluted EPS $0.79 (co. press release)
Q3 2026 Guidance
$520M ±5%
Record · +31% YoY, +13% QoQ (Aug 4, 2026 release)
SiPho Run Rate
$680M
Q2'26 annualized, vs $180M a year ago · $1B+ targeted by Q4'26
2028 Model
$3.6B / $1.2B
Revenue / net profit, 'fully spoken for by our customers'
Valuation
68x / 40x
FY26 ($3.86) / FY27 ($6.51) consensus EPS — vs GFS 23.5x, UMC 19.4x fwd (stockanalysis.com)

Quarterly Revenue — company press releases (EDGAR XBRL lags for this FPI)

$395.7M
Q3 2025
$440M
Q4 2025
$414M
Q1 2026
$460M
Q2 2026

From niche analog foundry to AI photonics pure-play

$680M → $1B+
SiPho annual run rate
Q2 2026 run rate, up from $180M a year earlier; company targets crossing a $1B run rate in Q4 2026 (Q2'26 press release)
$1.3B
Contracted 2027 SiPho revenue
Signed customer contracts announced May 13, 2026, with $290M in prepayments reserving capacity — management hinted the full 2027 SiPho forecast is higher
$3.6B / $1.2B
2028 revenue / net profit model
Raised with Q2'26 results (Aug 4, 2026), described as 'fully spoken for by our customers' — vs ~$1.57B revenue in 2025
NOV 2026
Q3 2026 print — record $520M guided
Guidance of $520M ±5% (+31% YoY, +13% QoQ) set Aug 4; a third straight record quarter would confirm the ramp is on schedule. Earnings date Nov 9, 2026.
Q4 2026
SiPho crosses the $1B run rate
Management's stated target for silicon photonics to exceed a $1B annualized revenue run rate — the key proof point for the 2027 contracts.
2027
$1.3B contracted SiPho year · Arai fab ready
Contracted SiPho revenue converts to P&L; repurposed Arai facility (ex-Fab 6) reaches full 300mm SiPho + advanced-packaging production readiness in Q4 2027.
2027–28
$3B Japan expansion (METI-backed)
Dual-track plan announced July 14, 2026: ~$3B net investment after ~$1B Japanese government grants, incl. a new 300mm fab adjacent to Fab 7 in Uozu for a multi-fold SiPho/SiGe capacity increase.
2028
The $3.6B / $1.2B model — judgment year
Customer-backed target of $3.6B revenue and $1.2B net profit; Nvidia (1.6T optical modules) and Marvell (5M+ coherent PICs shipped) collaborations underpin the demand case.

Forward Estimates, Surprises & Insider Activity

Forward Earnings Estimates

FY+1 EPS Consensus$3.86 FY2026 consensus (StockAnalysis; Barchart $3.57, range $3.50–$3.63) — ~68% growth
FY+2 EPS Consensus$6.51 FY2027 consensus (StockAnalysis; Barchart $6.20, range $5.68–$6.71) — ~69% growth
PEG Ratio~1.0 (forward P/E ~68x ÷ ~68% FY26→FY27 consensus EPS growth) — high multiple but roughly growth-matched
Forward P/E68.4× FY2026 EPS of $3.86; ~40.5× FY2027 EPS at $263.73
EPS Revisions (90d)↑3+ sell-side raises/initiations in ~90 days (Wedbush $140→$300, Benchmark $230→$335, BofA init $367); Barchart FY26/FY27 ranges all revised up post-Q2 ↓0 found (Sharply higher — FY2027 consensus (~$6.2–6.5) now anticipates the company's own former '2027 model' EPS of ~$6.52)
Guidance AccuracyStrong: guided Q2 2026 to $455M mid ±5%, delivered $460M; guided Q4 2025 to a record $440M, delivered $440M; company has hit or beaten its own midpoint in every recent quarter (company press releases)

Earnings Surprise Track Record

Q3 2025 (Sep) Est: $0.47 Act: $0.47 0.0%
Q4 2025 (Dec) Est: $0.59 Act: $0.70 +18.6%
Q1 2026 (Mar) Est: $0.49 Act: $0.57 +16.3%
Q2 2026 (Jun) Est: $0.69 Act: $0.79 +14.5%
Beat Rate3 of 4 beats (one in-line, zero misses); last three quarters each beat by 14%+ (Barchart)

Insider Activity (90 Days)

Net Buying/Selling−$60M (all sales, zero purchases in the last three months — Simply Wall St)
Sell/Buy RatioSales only — no reported insider buys
Negative signal, partly mitigated by mechanics: the selling is concentrated in the CEO and executed under pre-arranged instructions set March 12, 2026 (when not in possession of MNPI), against vested RSUs — but the scale (CEO liquidated ~42% of his holdings into the rally) is a genuine red flag flagged by Simply Wall St.
CEO Russell Ellwanger sold 181,535 shares on Aug 10–11, 2026 (~$40M+ at avg ~$248–251, incl. 104,226 shares at $248.34 = $25.9M), after an earlier $8.5M sale at $218 (Form 4 filings via StockTitan/MarketBeat/StreetInsider).

Relative Valuation vs. Competitors

CompanyP/E (fwd)EV/RevRev GrowthGross Margin
Tower Semiconductor~52x NTM (68x FY26)16.6x+24% YoY (Q2'26)30.0% (Q2'26)
GlobalFoundries23.5x4.0x+6% YoY (Q2'26)29.9% non-IFRS (Q2'26)
United Microelectronics19.4x5.6x+17% YoY (Q2'26)32.5% (Q2'26)
X-FAB Silicon Foundries~45x (ttm)~1.2x−7% YoY (Q2'26)n/a (16.8% EBITDA mgn)
TSEM carries the richest multiples in the specialty-foundry group by a wide margin — ~52x NTM earnings and 16.6x EV/Sales versus 19–24x and 1–6x for peers (stockanalysis.com, Aug 2026) — despite a Q2'26 gross margin (30%) that is merely in line with GFS and below UMC. The premium is entirely a growth bet: TSEM's +24% YoY growth (guided to +31% in Q3) and tripling SiPho line dwarf peers, and its $3.6B customer-backed 2028 model implies revenue more than doubling from 2025's ~$1.57B. Notably, competitors are chasing the same prize — UMC has pointed 90% of an expanded $2.0B 2026 capex at 12-inch capacity including silicon photonics, and GFS cites optical networking as a growth driver — so Tower's contracted-and-prepaid 2027 book is the moat that must hold.

Price Targets & Scenarios

ScenarioPrice TargetAssumptionsProbability
SiPho $1B Run Rate + 2028 Model Raised Again$350Q3/Q4 2026 prints land at or above guidance, silicon photonics crosses the $1B run rate on schedule, the Japan expansion stays on track, and FY2027 EPS tracks toward ~$7 as the 2028 model gets raised. The market pays ~50x on rising FY27 numbers — the BofA $367 zone becomes the magnet.30%
Execution On Track, Multiple Settles$293Records continue but at guided (not blowout) pace. FY2027 consensus EPS of $6.51 holds; the multiple settles at ~45x forward — still a large premium to GFS/UMC, earned by 2–3x their growth and a contracted, prepaid 2027 book — as the stock digests the five-bagger year.45%
AI-Capex Digestion or Ramp Slip$165A hyperscaler optics digestion phase, a Japan/Arai ramp delay, or a single large SiPho customer push-out cuts FY2027 EPS toward ~$5.50 and compresses the multiple to ~30x. With IV at its 100th percentile and a ~96% realized-vol tape, the unwind is fast — this is roughly a retest of the May consolidation zone.25%

Probability-Weighted Target: $278 (+5% vs $263.73 — a fair-value verdict: exceptional, contracted growth already carrying an exceptional multiple)

$278
Weighted
Bull $35030%
Base $29345%
Bear $16525%

Analyst Consensus

BofA Securities
$367
Initiated Buy on 2026-08-07 — called TSEM an AI data-center 'sleeper' on silicon photonics; stock jumped on the note (TheStreet, Yahoo Finance)
Benchmark (Cody Acree)
$335
Raised target to $335 from $230, Buy reiterated after record Q2 2026 and the new $3.6B 2028 model (Investing.com)
Susquehanna
$330
Raised target to $330 from $180, Positive, on 2026-05-14 after Q1 2026 results, capacity expansion and revised long-term RF-infrastructure targets (Insider Monkey)
Wedbush
$300
Raised target to $300 from $140 post-Q2 2026, kept Neutral (Quiver Quantitative / TheFly)
4 Buy · 1 Hold · 0 Sell — StockAnalysis.com shows a Strong Buy consensus (4 Strong Buy, 1 Hold, 0 Sell) with an average target of $321.32 (high $355, low $278) vs $263.73 — about +22% implied upside. Targets have been re-rated violently upward in 2026 (Wedbush $140→$300, Benchmark $230→$335, Susquehanna $180→$330, BofA initiating at $367) as silicon-photonics/AI datacenter revenue scaled.

Key Levels & Options Intelligence

S/RSupport & Resistance

BofA street-high target
$367
52-week high (Aug 2026)
$319.94
Volume-accumulation resistance
$270.77
Current price (Aug 17, 2026)
$263.73
Near support $247.75 / 50-DMA $244.44
$244–248
Secondary support (May–Jun consolidation)
$214–224
200-DMA
$176.45
52-week low (pre-inflection)
$47.97

OptOptions & Sentiment

  • Put/Call volume ratio: 0.34 — bullish call-heavy flow (Barchart/Fintel)
  • Put/Call open interest: 0.98 — balanced positioning
  • Implied volatility: ~115% (Volafy) — extremely elevated
  • IV rank / percentile: 100 / 100th percentile — richest options pricing in a year
  • Historical volatility: ~96% realized — IV trading above realized
  • Expected move (5-day): ~$19.8 (~8.4%)
  • Short interest: 2.72M shares, ~2.4% of float, 1.4 days to cover — low, but +99% y/y
  • Momentum read: RSI(14) 57.7 — constructive, not overbought; price above the rising 50-DMA ($244.44)

Systematic Conviction Score: 63/100 (Medium)

80
Analyst Alignment
30%
55
FCF Visibility
25%
80
Catalyst Clarity
20%
18
Valuation Safety
15%
65
Mgmt Quality
10%
Strong Buy consensus with targets re-rated from ~$226 to ~$335 avg and BofA initiating at a street-high $367 — the street sits well above the tape (80). Cash generation is real — record 30% gross / 20% net margins with $290M of customer prepayments — but half of a $920M capex program plus a ~$3B Japan build sit ahead of it (55). Catalysts are unusually dated and specific: Nov 9 Q3 print guided to a record $520M, a $1B SiPho run-rate target by Q4, $1.3B of contracted 2027 revenue, a published 2028 model (80). Valuation is the weak leg: ~68x FY26 / ~40x FY27 EPS, ~17x EV/sales — triple the peer group with no margin of safety on a miss (18). Management just delivered the best quarter in company history and has guided accurately for years, but the CEO selling ~42% of his stake into the rally tempers the signal (65). Weighted score 63 — Medium conviction: right business, demanding price.

Risk Assessment & Insider Signals

OOwnership & Insider Signals

  • Broad institutional base — ~70% of the stock: 328 institutions have filed 13D/G or 13F forms holding ~73.2M shares; hedge funds and institutions own roughly 70.5% of the company (Fintel/MarketBeat).
  • T. Rowe Price is the anchor holder at 6.6%: T. Rowe Price disclosed a 7.39M-share passive stake (6.6%) via Schedule 13G (StockTitan) — the largest single US institutional position.
  • Heavy Israeli institutional ownership: Clal Insurance, Phoenix Holdings, Migdal Insurance and Harel Insurance are all top-10 holders (Fintel) — a home-market institutional core that has held through the run.
  • Passive giants present: Vanguard, BlackRock, Goldman Sachs and Capital International Investors round out the top holders, giving steady index/quasi-index demand.
  • Active funds still adding in H1 2026: Calamos Advisors lifted its stake 439.9% in Q1 (to 133,597 shares) and Plato Investment Management opened a new position in Q2, per recent 13F filings.
  • Tiny insider ownership, low short interest: Insiders own only ~0.4% (~$101M, Simply Wall St). Short interest is 2.72M shares — ~2.4–2.5% of float, 1.4 days to cover — low in absolute terms, though roughly doubled (+99%) since August 2025 (Fintel/Benzinga).

Quantified Risk Assessment

Severity Risk Factor Prob. PT Impact
High Valuation / multiple-compression after a ~5x run
Bears (Seeking Alpha, Aug 2026) flag TSEM at ~70x 2026 EPS and ~17.3x EV/sales with 'no margin of safety'; GuruFocus puts the P/E ~268% above its 5-year median of 28x and scores the stock 'overvalued' vs GF Value. Any guidance miss risks sharp de-rating — the stock already dropped ~10–12% on single sessions this month on profit-taking alone.
45% -30%
High AI-capex-cycle dependence via silicon photonics
SiPho revenue grew 270% YoY to a $680M annualized run rate (Q2 2026 call), with a $1B run-rate target by Q4 2026 — the entire re-rating rests on optical interconnects replacing copper in AI datacenters. A pause in hyperscaler AI capex would hit the highest-multiple part of the story hardest.
35% -25%
Medium Execution on $920M capex plan and the 2028 model
Tower is executing a $920M capex program for SiGe/SiPho equipment (50% paid, rest through 2027) and guides a 2028 model of $3.6B revenue at 33% net margin assuming 85% utilization across fabs. Bear commentary centers on over-committing on capex; slippage on ramps or utilization breaks the model.
30% -20%
Medium Customer / demand concentration in SiPho contracts
The $1.3B of 2027 silicon-photonics revenue contracts announced May 2026 were signed 'with its largest customers' (company PR), and Simply Wall St notes the prepaid contracts 'sharpen the key risk around demand concentration.' Loss or push-out from one large optical customer moves the whole growth line.
25% -15%
Medium Israel geopolitical exposure
Headquarters and two fabs sit in Migdal HaEmek; during the Iran/Hezbollah conflict missiles flew over the plant (Calcalist/CTech), and Red Sea disruption shows Israeli supply-chain fragility. Mitigant: fabs in the US, Japan (TPSCo), Italy (ST Agrate) and Intel New Mexico capacity diversify the footprint.
20% -15%
Low Japan-expansion funding / dilution risk
Simply Wall St flags dilution risk from funding the Japanese capacity expansion as a momentum-breaker; with half the $920M capex still to be paid through 2027 and a ~$3B (net) Japan build ahead, financing choices (equity vs cash) are a live swing factor for per-share economics.
20% -10%

Summary

Rating
HOLD
Conviction
Medium
Price Target
$278
Timeframe
12 months
Upside
+5%
Position Size
2–3% via pullback tranches; 4% max only at the 200-DMA

Entry Strategy

1
Tranche 1 — 40%
$244–248
First add only at the 50-DMA / near-support shelf ($247.75 support, 50-DMA $244.44). With IV at its 100th percentile and ~8% weekly expected moves, pullbacks to this zone are routine — do not chase the tape above the $270.77 resistance.
2
Tranche 2 — 30%
$214–224
Add in the May–Jun consolidation zone if an AI-sector risk-off or post-earnings digestion drags the stock there with the SiPho ramp still intact (Q3 print on track, $1B run-rate target unchanged).
3
Tranche 3 — 30%
~$176
Full position only at the 200-DMA — historically the price of a genuine growth scare. Re-check the thesis first: if the drop came from a contracted-customer push-out or a Japan ramp delay, the 2028 model is broken and this tranche does not deploy.
DATA PROVENANCE: Figures as of Aug 18, 2026. Next catalyst: Q3 2026 earnings — Nov 9, 2026 (guided to a record $520M ±5%, +31% YoY; consensus EPS ~$0.98); interim: SiPho crossing the $1B run rate in Q4 2026. Primary sources: SEC EDGAR 6-K/20-F filings (CIK 0000928876) · Yahoo Finance quote & history · Tower Semiconductor Q2 2026 record results & Q3 guidance (GlobeNewswire, 2026-08-04) · Tower Semiconductor $3B METI-supported Japan capacity expansion (GlobeNewswire, 2026-07-14). Hard figures are sourced from the filings above; targets and ratings are interpretation, not a guarantee.
IMPORTANT DISCLAIMER: This analysis is for educational and research purposes only. Not financial advice. Past performance does not guarantee future results. Consult qualified financial professionals before making investment decisions. All investments carry risk of loss. The information presented is based on publicly available data as of Aug 18, 2026.